We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GRASSLEY SEEKS REVIEW OF FDA DRUG SAFETY SYSTEM
GRASSLEY SEEKS REVIEW OF FDA DRUG SAFETY SYSTEM
July 9, 2004
Concerned that a department charged with protecting the public interest appears to be a “lapdog” with little independence, a key Republican lawmaker is urging the General Accounting Office (GAO) to conduct a broad review of the FDA’s drug safety arm.